Spectral Ai, INC 8-K filings

Spectral AI, Inc. reports the resignation of its Chief Operating Officer, Dr. Niko Pagoulatos, and the appointment of Stan Micek as interim COO, effective April 8, 2024.

Spectral AI has appointed Jeremiah Sparks as Chief Commercialization Officer to lead the market entry of their DeepView wound care technology.

Spectral AI announced its 2023 financial results, highlighting a significant government contract and the expectation of first commercial revenue in the second half of 2024.

Spectral AI has entered into a standby equity purchase agreement with YA II PN, Ltd., providing access to up to $30 million in funding.

Spectral AI has appointed Peter M. Carlson as CEO, succeeding Wensheng Fan, and announced preliminary 2023 R&D revenue of $18 million while reaffirming 2024 revenue guidance of $28 million.

Spectral AI's DeepView AI-Burn software has secured UKCA authorization, paving the way for commercialization and revenue generation in the UK starting in the second half of 2024.

Spectral AI, a Dallas-based company, is revolutionizing wound care with its AI-driven DeepView system, supported by significant non-dilutive government funding and recent achievements including a $149 million BARDA contract.

Spectral AI has appointed Dr. J. Michael DiMaio, a company founder and former CEO, to its Board of Directors and secured a six-month lock-up extension from its two largest shareholders.

Spectral AI is transitioning to commercialization of its AI-driven wound care technology, highlighted by a $149 million BARDA contract and regulatory approvals.

Michael Murphy resigned from the Board of Directors of Spectral AI, effective January 30, 2024.